eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.
Casadei Gardini A, Marisi G, Faloppi L, Scarpi E, Foschi FG, Iavarone M, Lauletta G, Corbelli J, Valgiusti M, Facchetti F, Della Corte C, Neri LM, Tamberi S, Cascinu S, Scartozzi M, Amadori D, Nanni O, Tenti E, Ulivi P, Frassineti GL.
Casadei Gardini A, et al. Among authors: valgiusti m.
Oncotarget. 2016 May 10;7(19):27988-99. doi: 10.18632/oncotarget.8569.
Oncotarget. 2016.
PMID: 27058899
Free PMC article.